Navigation Links
DiaSorin Webinar Spotlights Primary Hyperaldosteronism From A to Z
Date:4/7/2016

The occurrence of primary hyperaldosteronism among general and resistant hypertensive populations is widespread, ranging from five to 20 percent. This disorder, which is considered a secondary form of hypertension—caused by improper secretion of aldosterone and activation of the mineralocorticoid receptor—is a highly treatable and potentially curable form of hypertension.

DiaSorin is sponsoring a new, free educational webinar, “Primary Hyperaldosteronism: From A to Z,” which will discuss the prevalence, pathophysiology, screening and diagnostic studies, and treatment options for patients with primary hyperaldosteronism so that physicians can accurately screen and identify cases. Continuing education credits will be offered through the PACE system.

The speaker is Jonathan Williams, MD, MMSc, assistant professor of medicine at Harvard Medical School, and associate physician at Brigham and Women’s Hospital, Division of Endocrinology, Diabetes, and Hypertension. Dr. Williams has devoted his research efforts to deciphering the intricate relationship between genetics and environment with respect to individual susceptibility to cardiometabolic disease. He has more than 40 original publications describing the physiologic and pathologic interplay of renin-angiotensin-aldosterone system activity and dietary salt intake in hypertension, insulin resistance, heart disease, and obesity. Dr. Williams is an active program developer, course director, and mentor for the Harvard Medical School’s Scholars in Clinical Research Program. His complete bio is found on the LabRoots website.

The free webinar, hosted by LabRoots, will be presented on April 14, 2016, at 9 am PT/11 am CT/12 pm ET.

For full details about the event, obtaining continuing education credits, and free registration, click here.

About DiaSorin:
DiaSorin Inc. offers the broadest, fully automated Infectious Disease and Specialty Diagnostics menu including the Best-in-Class Vitamin D. These quality assays are analyzed on the versatile LIAISON® XL platform. We provide value through sales, service and support solutions to clinical laboratories by consolidating their menu in order to streamline processes and increase efficiency.

About LabRoots:
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2016/04/prweb13322975.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. DiaSorin Announces New Webinar in Their Annual Vitamin D Series
2. Diasorin Announces New Webinar Highlighting Syphilis Diagnosis
3. LabRoots, Inc to Host DiaSorin Webinar that Tackles Clinical Conundrum of Vitamin D Testing and Treatment
4. LabRoots Hosts DiaSorin Webinar that Spotlights Herpes Serology Testing from the Public Health Perspective
5. Webinar: Comparing Prices in Group Health vs. Workers' Compensation
6. 1 EDI Source Presents the Big Picture in Final Healthcare HIPAA EDI Webinar of 2013
7. Register to Download the Webinar Playback -- Middle Market Insights: Banking, Lending and the Impact on M&A
8. Self-Pleasure as a Healing Practice, a Complimentary Sexual Health Webinar from Sinclair Institute®
9. Biopharm Insight Hosts Educational Webinar Ahead of American Society of Hematology Conference Next Month
10. Register to Join the Merrill DataSite's Webinar: Avoiding the Post-Merger Blues: How to Reduce the Risk of Post-deal Disputes
11. Life Technologies Announces New Webinar Learning Series with BioConference Live
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... Georgia Urology , ... Dr. Brent Sharpe who is now serving urology patients in the Braselton and ... in Flowery Branch, and is open on Mondays, Tuesdays, Wednesdays, and Fridays. The Gainesville ...
(Date:7/27/2017)... (PRWEB) , ... July 27, 2017 , ... ... a new set of teeth in a single office visit from Dr. Alejandro ... comfortable treatment solutions to his East Texas patients, including Teeth-in-a-Day® dental implants ...
(Date:7/27/2017)... Santa Clara, CA (PRWEB) , ... July 27, ... ... technology, announces the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution ... to support accelerated diagnostics and sleep care management. The speed and functionality of ...
(Date:7/27/2017)... ... ... Los Angeles leg of the US movie premier of the Man in the Camo Jacket ... Clive Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the LA ... rock musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer and ...
(Date:7/27/2017)... ... 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, ... a stagiaire for the remainder of the 2017 season. One of our best development ... Tour of Utah. , “Every season we are excited to move an athlete from ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... 11, 2017  Sysmex America, Inc., a leading ... equipment as well as middleware information systems technology, ... make quality assurance easier and more risk free ... known for the innovation that it delivers to ... quality assurance processes to a new level with ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology: